Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079417 · ClinicalTrials.gov registry record · Phase 3
Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
A Phase 3 study of Intraocular Retinoblastoma, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 28
- Enrollment target
- 10
- Study locations
NCT00079417 is a Phase 3 study of Intraocular Retinoblastoma that has completed, run by Children's Oncology Group. The registered enrollment target is 28 participants. The trial reports 10 study locations across 9 states.
The verdict
NCT00079417, a Phase 3 study of Intraocular Retinoblastoma, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 28 participants
- Enrollment target
- 10
- Study locations
Study Summary
This phase III trial is studying how well giving carboplatin and vincristine together with standard local ophthalmic therapy works in treating children with intraocular retinoblastoma. Drugs used in chemotherapy, such as carboplatin and vincristine, work in different ways to stop tumor from dividing so they stop growing or die. It is not yet known whether neoadjuvant chemotherapy combined with standard local ophthalmic therapy is effective in treating intraocular retinoblastoma.
Conditions Studied
Interventions
- DRUG Carboplatin
- RADIATION Radiation Therapy
- PROCEDURE Cryosurgery
- PROCEDURE Infrared Laser Therapy
- RADIATION Iodine I-125
Study Locations (10)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Oncology Group - Philadelphia
California
- Children's Hospital Los Angeles - Los Angeles
Illinois
- Lurie Children's Hospital-Chicago - Chicago
Massachusetts
- Dana-Farber Cancer Institute - Boston
Michigan
- Wayne State University/Karmanos Cancer Institute - Detroit
North Carolina
- Duke University Medical Center - Durham
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Texas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2005-12-26 |
| Est. Completion | 2017-03-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00079417
The ClinicalTrials.gov registry entry for NCT00079417 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intraocular Retinoblastoma appearing as the primary indexed condition, and to 5 interventions - of which Carboplatin is the first listed.
NCT00079417 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Pennsylvania, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT00079417 about?
NCT00079417 is a clinical study titled "Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma". This phase III trial is studying how well giving carboplatin and vincristine together with standard local ophthalmic therapy works in treating children with intraocular retinoblastoma. Drugs used in chemotherapy, such as carboplatin and vincristine, work in different ways to stop tumor from dividing...
What is the current status of trial NCT00079417?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 28 participants. The study started on 2005-12-26. Estimated completion is 2017-03-31.
What conditions does trial NCT00079417 study?
This clinical trial studies the following conditions: Intraocular Retinoblastoma.
What interventions are being tested in trial NCT00079417?
The interventions under investigation include: Carboplatin (DRUG), Radiation Therapy (RADIATION), Cryosurgery (PROCEDURE), Infrared Laser Therapy (PROCEDURE), Iodine I-125 (RADIATION).
Who is sponsoring clinical trial NCT00079417?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00079417 being conducted?
This trial has 10 study locations across California, Illinois, Massachusetts, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Retinoblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.